INVESCO EXCHANGE TRADED FD T - BIOTECHNOLOGY (PBE)

CUSIP: 46137V787

Q3 2020 13F Holders as of 30 Sep 2020

Share change
+13,293
SEC-reported price per share
$56.62
Number of holders
71
Value change
+$730,115
Number of buys
21
Number of sells
28

Security key

46137V787

Report period

Q3 2020

Institutions

71

Top holders

10

Ownership snapshot

Top reported holders of PBE - INVESCO EXCHANGE TRADED FD T - BIOTECHNOLOGY (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Disclosed value leader
Comparable rows
0/0
Latest evidence
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.

13F holder rows

Institutional holders as of Q3 2020

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
71
Shares
925,697
Rows available
71
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2020 vs Q2 2020 Across Filers

Q2 2020 holders
75
Q3 2020 holders
71
Holder diff
-4
Investor Q2 2020 Shares Q3 2020 Shares Share Diff Share Chg % Q2 2020 value Q3 2020 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .